Methodological approaches to the study of metabolism across individual tissues in man

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 8, Issue 5, 2005, Pages 501-510

  Magkos, Faidon ^a,b   Sidossis, Labros S ^a  

^a HAROKOPIO UNIVERSITY   (Greece)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriovenous; Energy metabolism; Microdialysis; Nuclear magnetic resonance; Regional; Substrate flux

Indexed keywords

CARBON; HYDROGEN; PHOSPHORUS;

ADIPOSE TISSUE; ARTERY BLOOD FLOW; BLOOD FLOW; BRAIN METABOLISM; ENERGY METABOLISM; HEART MUSCLE METABOLISM; HEART OUTPUT; HUMAN; IN VIVO STUDY; KIDNEY METABOLISM; LIVER METABOLISM; MAGNETIC FIELD; METABOLIC RATE; MICRODIALYSIS; MUSCLE METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; TISSUE METABOLISM;

EID: 23944514298     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/01.mco.0000170756.71114.78     Document Type: Review

References (87)

1. Elia M. Organ and tissue contribution to metabolic rate. In: Kinney JM, Tucker HN, editors. Energy metabolism: tissue determinants and cellular corollaries. New York: Raven Press; 1992. pp. 61-79.
2. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 1975; 35:609-616.
3. Macdonald IA. Arterio-venous differences to study macronutrient metabolism: introduction and overview. Proc Nutr Soc 1999; 58:871-875.
4. Butler PC, Home PD. The measurement of metabolite exchange across muscle beds. Baillieres Clin Endocrinol Metab 1987; 1:863-878.
5. Zierler KL. Theory of the use of arteriovenous concentration differences for measuring metabolism in steady and non-steady states. J Clin Invest 1961; 40:2111-2125.
6. DeFronzo RA. Use of the splanchnic/hepatic balance technique in the study of glucose metabolism. Baillieres Clin Endocrinol Metab 1987; 1:837-862.
7. Frayn KN, Lund P, Walker M. Interpretation of oxygen and carbon dioxide exchange across tissue beds in vivo. Clin Sci (Lond) 1993; 85:373-384.
8. Frayn KN, Coppack SW, Humphreys SM. Subcutaneous adipose tissue metabolism studied by local catheterization. Int J Obes Relat Metab Disord 1993; 17 (Suppl 3):S18-S21.
9. Frayn KN, Macdonald IA. Assessment of substrate and energy metabolism in vivo. In: Draznin B, Rizza R, editors. Clinical research in diabetes and obesity. Volume I: Methods, assessment, and metabolic regulation. Totowa, NJ: Humana Press; 1997. pp. 101-124.
10. Frayn KN. Macronutrient metabolism of adipose tissue at rest and during exercise: a methodological viewpoint. Proc Nutr Soc 1999; 58:877-886.
11. van Hall G, Gonzalez-Alonso J, Sacchetti M, Saltin B. Skeletal muscle substrate metabolism during exercise: methodological considerations. Proc Nutr Soc 1999; 58:899-912.
12. Radegran G. Limb and skeletal muscle blood flow measurements at rest and during exercise in human subjects. Proc Nutr Soc 1999; 58:887-898.
13. Magkos F, Sidossis LS. Measuring very low density lipoprotein- triglyceride kinetics in man in vivo: how different the various methods really are. Curr Opin Clin Nutr Metab Care 2004; 7:547-555. Reviews several methods for studying the dynamics of triglyceride metabolism in man, including the splanchnic arteriovenous balance technique.
14. Jensen MD, Ekberg K, Landau BR. Lipid metabolism during fasting. Am J Physiol Endocrinol Metab 2001; 281:E789-E793.
15. van Hall G, Jensen-Urstad M, Rosdahl H, et al. Leg and arm lactate and substrate kinetics during exercise. Am J Physiol Endocrinol Metab 2003; 284:E193-E205.
16. 133xenon methods).
17. Simonsen L, Henriksen O, Enevoldsen LH, Bulow J. The effect of exercise on regional adipose tissue and splanchnic lipid metabolism in overweight type 2 diabetic subjects. Diabetologia 2004; 47:652-659. Similar in experimental design to [16].
18. Jensen MD, Johnson CM. Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive FFA flux in men and women. Metabolism 1996; 45:662-666.
19. Jensen MD. Assessment of free fatty acid metabolism. In: Draznin B, Rizza R, editors. Clinical research in diabetes and obesity. Volume I: Methods, assessment, and metabolic regulation. Totowa, NJ: Humana Press; 1997. pp. 125-136.
20. Basu A, Basu R, Shah P, et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 2001; 50:1351-1362.
21. Basu A, Basu R, Shah P, et al. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 2001; 280:E1000-E1006.
22. Shah P, Vella A, Basu A, et al. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 2002; 51:301-310.
23. Shah P, Vella A, Basu A, et al. Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes 2003; 52:38-42.
24. Basu A, Basu R, Shah P, et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 2000; 49:272-283.
25. Meek SE, Persson M, Ford GC, Nair KS. Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes 1998; 47:1824-1835.
26. Nguyen TT, Mijares AH, Johnson CM, Jensen MD. Postprandial leg and splanchnic fatty acid metabolism in nonobese men and women. Am J Physiol Endocrinol Metab 1996; 271:E965-E972.
27. Sidossis LS, Mittendorfer B, Walser E, Wolfe RR. Regional disposal of intravenously infused glucose during prolonged hyperglycemia-hyperinsulinemia. J Nutr Biochem 1999; 10:547-554.
28. Nielsen S, Guo Z, Johnson CM, et al. Splanchnic lipolysis in human obesity. J Clin Invest 2004; 113:1582-1588. Uses catheterizations of the femoral artery, femoral vein and hepatic vein, in conjunction with radio-labelled fatty acid tracers, to determine the effects of gender and obesity on fatty acid uptake and release at the whole-body, lower-body, splanchnic region, and nonsplanchnic upper-body region. Also, makes use of a model developed in chronically catheterized dogs at the hepatic arterial, portal venous, and hepatic venous circulation to derive estimates of hepatic fatty acid delivery via the portal vein in humans (assumed to arise from visceral adipose tissue lipolysis).
29. Jensen MD, Cardin S, Edgerton D, Cherrington A. Splanchnic free fatty acid kinetics. Am J Physiol Endocrinol Metab 2003; 284:E1140-E1148.
30. Sidossis LS, Mittendorfer B, Chinkes D, et al. Effect of hyperglycemia-hyperinsulinemia on whole body and regional fatty acid metabolism. Am J Physiol Endocrinol Metab 1999; 276:E427-E434.
31. Sidossis LS, Mittendorfer B, Walser E, et al. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol Endocrinol Metab 1998; 275:E798-E805.
32. Mittendorfer B, Sidossis LS. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets. Am J Clin Nutr 2001; 73:892-899.
33. Mittendorfer B, Sidossis LS, Walser E, et al. Regional acetate kinetics and oxidation in human volunteers. Am J Physiol Endocrinol Metab 1998; 274:E978-E983.
34. de la Pena A, Liu P, Derendorf H. Microdialysis in peripheral tissues. Adv Drug Deliv Rev 2000; 45:189-216.
35. Arner P. Microdialysis: use in human exercise studies. Proc Nutr Soc 1999; 58:913-917.
36. Arner P, Bulow J. Assessment of adipose tissue metabolism in man: comparison of Pick and microdialysis techniques. Clin Sci (Lond) 1993; 85:247-256.
37. Kehr J. A survey on quantitative microdialysis: theoretical models and practical implications. J Neurosci Methods 1993; 48:251-261.
38. Stahl M, Bouw R, Jackson A, Pay V. Human microdialysis. Curr Pharm Biotechnol 2002; 3:165-178.
39. Chaurasia CS. In vivo microdialysis sampling: theory and applications. Biomed Chromatogr 1999; 13:317-332.
40. Henriksson J. Microdialysis of skeletal muscle at rest. Proc Nutr Soc 1999; 58:919-923.
41. Lonnroth P. Microdialysis in adipose tissue and skeletal muscle. Horm Metab Res 1997; 29:344-346.
42. Ungerstedt U. Microdialysis: principles and applications for studies in animals and man. J Intern Med 1991; 230:365-373.
43. Rooyackers O, Thorell A, Nygren J, Ljungqvist O. Microdialysis methods for measuring human metabolism. Curr Opin Clin Nutr Metab Care 2004; 7:515-521. Discusses several recent applications of microdialysis, including its potential for use as a diagnostic tool.
44. Rooyackers O. Microdialysis to investigate tissue amino acid kinetics. Curr Opin Clin Nutr Metab Care 2005; 8:77-82. Presents recent advances in the use of microdialysis for investigating regional amino acid metabolism, not only in skeletal muscle but also in the brain.
45. Barbe P, Darimont C, Saint-Marc P, Galitzky J. Measurements of white adipose tissue metabolism by microdialysis technique. Methods Mol Biol 2001; 155:305-321.
46. Arner P, Bounder J. Microdialysis of adipose tissue. J Intern Med 1991; 230:381-386.
47. Bangsbo J. Vasoactive substances in the interstitium of contracting skeletal muscle examined by microdialysis. Proc Nutr Soc 1999; 58:925-933.
48. Lott ME, Sinoway LI. What has microdialysis shown us about the metabolic milieu within exercising skeletal muscle? Exerc Sport Sci Rev 2004; 32: 69-74. Reviews a number of novel findings produced by microdialysis studies with respect to the role of muscle-derived endogenous compounds in the control of local circulation and pressor response during exercise. Demonstrates the great potential of the method for studying various aspects of regional metabolism.
49. Summers LK, Arner P, Ilic V, et al. Adipose tissue metabolism in the post-prandial period: microdialysis and arteriovenous techniques compared. Am J Physiol Endocrinol Metab 1998; 274:E651-E655.
50. Simonsen L, Bulow J, Madsen J. Adipose tissue metabolism in humans determined by vein catheterization and microdialysis techniques. Am J Physiol Endocrinol Metab 1994; 266:E357-E365.
51. Stallknecht B, Kiens B, Helge JW, et al. Interstitial glycerol concentrations in human skeletal muscle and adipose tissue during graded exercise. Acta Physiol Scand 2004; 180:367-377. Uses microdialysis with in-vivo probe calibration to study the lipolytic response of skeletal muscle and adipose tissue during rest and graded exercise. Shows that recovery of glycerol by the same catheter perfused at the same rate may vary between experimental conditions in a tissue-dependent manner.
52. Rooyackers O, Myrenfors P, Nygren J, et al. Insulin stimulated glucose disposal in peripheral tissues studied with microdialysis and stable isotope tracers. Clin Nutr 2004; 23:743-752. Uses different stable isotope tracers of glucose in the systemic circulation and in the microdialysis solution to quantify whole-body and regional (skeletal muscle and adipose tissue) glucose metabolism, respectively, in the basal state and during a euglycaemic - hyperinsulinaemic clamp. It demonstrates the usefulness of combining these methods for assessing the local mechanisms of insulin sensitivity and resistance in a relatively noninvasive manner.
53. Miller S, Chinkes D, MacLean DA, et al. In vivo muscle amino acid transport involves two distinct processes. Am J Physiol Endocrinol Metab 2004; 287:E136-E141. Employs several techniques (needle biopsy, arteriovenous balance, microdialysis, stable isotope tracers) for studying amino acid and protein metabolism in human skeletal muscle. Each method contributes a piece to an elaborate kinetic model for the transport of various amino acids across muscle.
54. Biolo G, Fleming RY, Maggi SP, Wolfe RR. Transmembrane transport and intracellular kinetics of amino acids in human skeletal muscle. Am J Physiol Endocrinol Metab 1995; 268:E75-E84.
55. Dobbins RL, Malloy CR. Measuring in-vivo metabolism using nuclear magnetic resonance. Curr Opin Clin Nutr Metab Care 2003; 6:501-509.
56. Wolfe RR, Chinkes DL. Isotope tracers in metabolic research: principles and practice of kinetic analysis. 2nd ed. Hoboken, NJ: John Wiley & Sons; 2005. pp. 421-448. Provides an updated collection of resources for the study of human metabolism in vivo with isotopic tracers; includes several new applications.
57. Murphy E, Hellerstein M. Is in vivo nuclear magnetic resonance spectroscopy currently a quantitative method for whole-body carbohydrate metabolism? Nutr Rev 2000; 58:304-314.
58. 31P magnetic resonance spectroscopy of (human) skeletal muscle. Proc Nutr Soc 1999; 58:861-870.
59. 31P NMR in the study of high-energy phosphate metabolism in human skeletal muscle under various experimental conditions (exercise, recovery, immobilization, alkalosis, heart failure).
60. Pathare N, Walter GA, Stevens JE, et al. Changes in inorganic phosphate and force production in human skeletal muscle after cast immobilization. J Appl Physiol 2005; 98:307-314. See annotation to Ref. [59].
61. Bendahan D, Giannesini B, Cozzone PJ. Functional investigations of exercising muscle: a noninvasive magnetic resonance spectroscopy-magnetic resonance imaging approach. Cell Mol Life Sci 2004; 61:1001-1015. See annotation to Ref. [59].
62. 31P MRS). Magn Reson Imaging 2004; 22:109-115. See annotation to Ref. [59].
63. Nagai T, Okita K, Yonezawa K, et al. Comparisons of the skeletal muscle metabolic abnormalities in the arm and leg muscles of patients with chronic heart failure. Circ J 2004; 68:573-579. See annotation to Ref. [59].
64. Raymer GH, Marsh GD, Kowalchuk JM, Thompson RT. Metabolic effects of induced alkalosis during progressive forearm exercise to fatigue. J Appl Physiol 2004; 96:2050-2056. See annotation to Ref. [59].
65. Roden M. Non-invasive studies of glycogen metabolism in human skeletal muscle using nuclear magnetic resonance spectroscopy. Curr Opin Clin Nutr Metab Care 2001; 4:261-266.
66. Roden M, Petersen KF, Shulman GI. Nuclear magnetic resonance studies of hepatic glucose metabolism in humans. Recent Prog Horm Res 2001; 56:219-237.
67. Roden M, Shulman GI. Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Annu Rev Med 1999; 50:277-290.
68. Shulman RG, Rothman DL, Price TB. Nuclear magnetic resonance studies of muscle and applications to exercise and diabetes. Diabetes 1996; 45 (Suppl 1):S93-S98.
69. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106:171-176.
70. Price TB, Rothman DL, Shulman RG. NMR of glycogen in exercise. Proc Nutr Soc 1999; 58:851-859.
71. 1H NMR to measure liver fat content and examine its relationship to the dynamic measures of hepatic carbohydrate metabolism.
72. 2]glucose to measure whole-body glucose production (and hence gluconeogenesis by subtraction).
73. 31P NMR spectroscopy simultaneously to quantify glycogen and high-energy phosphates in human skeletal muscle, respectively, in order to assess some of the metabolic features of delayed onset muscle soreness.
74. 1H nuclear magnetic resonance spectroscopy study. J Clin Endocrinol Metab 2000; 85:748-754.
75. 1H magnetic resonance spectroscopy. Proc Nutr Soc 1999; 58:841-850.
76. 1H NMR spectroscopy; also summarizes history, measurement techniques, and interpretation of muscle lipid data.
77. 1H NMR spectroscopy. Also presents a comprehensive analysis of intramyocellular lipid content and fibre orientation in various different muscles of man.
78. 1H NMR spectroscopy to quantify intramyocellular lipids in the tibialis anterior (mixed type I and type II fibres, predominantly type II) and the soleus (predominantly type I fibres) muscles of healthy volunteers. Measurements in the basal state (overnight fast) and during a progressive fasting indicate a substantial augmentation of intramuscular fat pool, to levels around 370% for tibialis anterior and 150% for soleus after 120 h of fasting (versus baseline).
79. 1H-MR spectroscopic imaging. J Appl Physiol 2001; 90:1267-1274.
80. Gan SK, Kriketos AD, Ellis BA, et al. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care 2003; 26:1706-1713.
81. 1H NMR spectroscopy) and whole-body adipose tissue content and distribution (by MRI) in a group of patients with biopsy-proven nonalcoholic fatty liver disease and healthy volunteers. Demonstrates that liver fat accumulation appears to be closely related to abdominal fat adiposity.
82. 1H NMR spectroscopy) and the size (volume) of intraabdominal and subcutaneous fat depots (by MRI) in a group of men and women without diabetes. Shows that women in general have more subcutaneous fat than men, but similar intraabdominal and liver fat; men and women matched for intraabdominal and liver fat do not exhibit sex differences in insulin resistance markers.
83. 5]glycerol to determine whole-body glucose and glycerol turnover, microdialysis to estimate rates of subcutaneous adipose tissue lipolysis, and indirect calorimetry to assess rates of whole-body energy expenditure and carbohydrate and fat oxidation, in the basal state and during euglycaemia-hyperinsulinaemia, in insulin-resistant offspring of patients with type 2 diabetes and matched insulin-sensitive controls.
84. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005; 288:E462-E468. A proton NMR spectroscopy study of epidemiological proportions. Shows that hepatic steatosis (>95th percentile) is surprisingly prevalent among urban US adult men and women (approximately one-third of the population).
85. Schick F, Machann J, Brechtel K, et al. MRI of muscular fat. Magn Reson Med 2002; 47:720-727.
86. Machann J, Bachmann OP, Brechtel K, et al. Lipid content in the musculature of the lower leg assessed by fat selective MRI: intra- and interindividual differences and correlation with anthropometric and metabolic data. J Magn Reson Imaging 2003; 17:350-357.
87. Goodpaster BH, Stenger VA, Boada F, et al. Skeletal muscle lipid concentration quantified by magnetic resonance imaging. Am J Clin Nutr 2004; 79:748-754. Presents a novel method (Refs [85,86] are similar) for quantifying fat content in human skeletal muscle in vivo by NMR imaging. Shows that the new technique is able to detect differences in lipid content among various muscle groups, as well as between normal-weight and obese individuals, and demonstrates the potential of MRI in clinical practice.